Supernus Pharmaceuticals Inc
SWB:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
H
|
Hanover Insurance Group Inc
F:AF4
|
US |
|
I
|
Illumina Inc
XMUN:ILU
|
US |
|
R
|
R&B Food Supply PCL
SET:RBF
|
TH |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
Wall St Price Targets
S49 Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for S49 is 55.45 EUR with a low forecast of 48.24 EUR and a high forecast of 61.09 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S49's stock price target?
Price Target
55.45
EUR
According to Wall Street analysts, the average 1-year price target for S49 is 55.45 EUR with a low forecast of 48.24 EUR and a high forecast of 61.09 EUR.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 59%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
61%
The compound annual growth rate for Operating Income over the next 8 years is 61%.
